Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 16 2026 9:02 AM

Full Issue

FDA Approves Lipfendra, A Daily Pill To Lower Cholesterol That Outperforms Statins

Clinical trials of enlicitide, under the brand name Lipfendra, have shown that it can bring levels of LDL — the dangerous type of cholesterol — down to 50 or 60 or even lower, which is far below what can be achieved with statins. The American Heart Association's cholesterol guidelines say LDL levels should be below 70 for those with above-average risk of heart attacks or strokes, The New York Times reported.

The New York Times: The F.D.A. Approves A New Pill To Slash Cholesterol Levels

The Food and Drug Administration approved a daily pill on Thursday that can lower cholesterol levels far below what can be achieved with statins, the cheap cholesterol-reducing pills. The drug, enlicitide, whose brand name is Lipfendra, is made by the pharmaceutical company Merck. Clinical trials have shown that it can bring levels of LDL — the dangerous type of cholesterol — down to 50 or 60 or even lower. Adults not taking cholesterol-lowering drugs usually have levels above 100. It works by inhibiting a protein known as PCSK9. (Kolata, 7/16)

More health and wellness news —

Stat: New Study Untangles How Epstein-Barr Virus Triggers Immune Response In MS 

In a new study published in Science Translational Medicine on Wednesday, researchers say they have uncovered how Epstein-Barr virus launches immune responses that lead to the inflammation and nervous system damage seen in people with multiple sclerosis. (Chen, 7/15)

MedPage Today: Study Offers Reassurance To Women Considering Epidural During Labor

Epidural analgesia in labor was not linked to adverse neonatal neurological outcomes, a Scottish cohort study found. An analysis of nearly half a million deliveries found no association between epidural analgesia in labor and neonatal neurological morbidity ..., reported Rachel Kearns, MBChB, MD, of Glasgow Royal Infirmary in Scotland, and colleagues. (Robertson, 7/15)

MedPage Today: Astronauts Obtain First X-Rays In Space

It was feasible to take x-rays in space, potentially improving diagnostic capabilities for crew health, according to a small prospective study. Using a portable radiography system, three crew members on the 3.5-day Fram2 polar orbital flight were able to take diagnostic-quality x-rays, the first human radiographs in space, reported Sheyna Gifford, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues. (Bassett, 7/15)

In celebrity news —

AP: Sam Neill Died From Pneumonia, His Agent Says

Actor Sam Neill died from pneumonia and will be honored at a private family memorial at his New Zealand farm later, his agent told The Associated Press on Thursday. Neill’s family had earlier announced the actor known for “Jurassic Park,” “The Piano” and other films died Monday in Sydney. (Graham-McLay, 7/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 16
  • Wednesday, July 15
  • Tuesday, July 14
  • Monday, July 13
  • Friday, July 10
  • Thursday, July 9
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF